Bevacizumab: Osteonecrosis of jaw.
In: Reactions Weekly, Jg. 2003 (2024-04-10), Heft 1, S. 171-171
serialPeriodical
Zugriff:
In a study involving 54 patients with colorectal or ovary cancer, two patients developed osteonecrosis of the jaw (ONJ) during treatment with bevacizumab. Both patients reported episodes of infections after starting bevacizumab therapy, and CT scans revealed jawbone alterations. The diagnosis of ONJ was made based on clinical presentation and laboratory test findings, and both patients were treated with antibiotics and discontinued bevacizumab therapy. The ONJ resolved after treatment. [Extracted from the article]
Titel: |
Bevacizumab: Osteonecrosis of jaw.
|
---|---|
Zeitschrift: | Reactions Weekly, Jg. 2003 (2024-04-10), Heft 1, S. 171-171 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 0114-9954 (print) |
DOI: | 10.1007/s40278-024-56002-8 |
Schlagwort: |
|
Sonstiges: |
|